[HTML] springer.comFull View

[HTML][HTML] CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

SS Puntambekar, M Moutinho, PBC Lin… - Molecular …, 2022 - Springer
Background Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …
被引用次数：43 相关文章
[HTML] biomedcentral.com

[HTML][HTML] CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

SS Puntambekar, M Moutinho… - Molecular …, 2022 - molecularneurodegeneration …
Despite its identification as a key checkpoint regulator of microglial activation in Alzheimer's
disease, the overarching role of CX3CR1 signaling in modulating mechanisms of Aβ driven …

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

SS Puntambekar, M Moutinho, PBC Lin, V Jadhav… - 2022 - scholarworks.iupui.edu
Background: Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

SS Puntambekar, M Moutinho, PBC Lin… - Molecular …, 2022 - search.proquest.com
Background Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …
[HTML] nih.gov

[HTML][HTML] CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

SS Puntambekar, M Moutinho, PBC Lin… - Molecular …, 2022 - ncbi.nlm.nih.gov
Background Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

SS Puntambekar, M Moutinho… - Molecular …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.

SS Puntambekar, M Moutinho… - Molecular …, 2022 - search.ebscohost.com
Background: Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.

SS Puntambekar, M Moutinho, PBC Lin… - Molecular …, 2022 - go.gale.com
Background Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …
[PDF] academia.edu

[PDF][PDF] CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

SS Puntambekar, M Moutinho, PBC Lin… - Molecular …, 2022 - academia.edu
Background: Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.

SS Puntambekar, M Moutinho, PB Lin… - Molecular …, 2022 - europepmc.org
Background Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …